CRISUGABALIN
UNII Q3MK7E8686

Substance Identification & Data

This profile provides standardized clinical and technical data for Crisugabalin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q3MK7E8686.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2209104-84-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q3MK7E8686

CAS Registry Number

2209104-84-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CRISUGABALIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H19NO2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WCEFMBSFXJUREW-LIJGXYGRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C199029

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

139300919

Unique identification number in the NCBI database of chemical substances.

INN ID

12414

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(O)=O)[C@@]1(CN)[C@@]2([C@@]3([C@]1(CC[C@H](C2)C3)[H])[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Crisugabalin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.